Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.6M Buy
160,158
+2,981
+2% +$349K 1.51% 21
2026
Q1
$18.9M Buy
157,177
+2,107
+1% +$243K 1.59% 22
2025
Q4
$16.3M Buy
155,070
+945
+0.6% +$88.7K 1.34% 30
2025
Q3
$12.9M Buy
154,125
+13,149
+9% +$1.08M 1.09% 35
2025
Q2
$11.2M Buy
140,976
+40,512
+40% +$3.22M 1.06% 39
2025
Q1
$9.02M Buy
100,464
+5,038
+5% +$470K 1.13% 35
2024
Q4
$9.49M Buy
95,426
+3,906
+4% +$403K 1.13% 36
2024
Q3
$10.4M Buy
91,520
+4,942
+6% +$587K 1.27% 32
2024
Q2
$10.7M Buy
86,578
+1,586
+2% +$204K 1.38% 28
2024
Q1
$11.2M Buy
84,992
+722
+0.9% +$89K 1.5% 25
2023
Q4
$9.19M Buy
84,270
+4,638
+6% +$481K 1.38% 27
2023
Q3
$8.2M Buy
79,632
+361
+0.5% +$38.9K 1.43% 28
2023
Q2
$9.15M Buy
79,271
+439
+0.6% +$49.8K 1.56% 19
2023
Q1
$8.39M Buy
78,832
+992
+1% +$107K 1.56% 26
2022
Q4
$8.64M Buy
+77,840
New +$7.96M 1.78% 20

Other funds holding MRK

Talbot Financial's MRK Position: Q2 2026 in Review

Talbot Financial increased its Merck (MRK) stake by 1.9% in Q2 2026, buying an estimated $349K and bringing the position to 160,158 shares worth $20.6M. The position accounts for 1.51% of the portfolio, ranked #21.

Talbot Financial first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Talbot Financial held 160,158 shares of Merck worth $20.6M as of Q2 2026.
  • Talbot Financial bought 2,981 Merck shares in Q2 2026, an estimated $349K.
  • Merck made up 1.51% of Talbot Financial's portfolio in Q2 2026, its #21 holding.
  • Talbot Financial first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Talbot Financial's 13F filing for Q2 2026, filed 14 Jul 2026.